Company Filing History:
Years Active: 1995
Title: Antal Simai: Innovator in Pharmaceutical Chemistry
Introduction
Antal Simai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzotriazepin derivatives. His research focuses on the development of compounds that have potential therapeutic applications.
Latest Patents
Antal Simai holds a patent for "1,3,4-benzotraizepin-5(4H)-one derivatives and process for the." This invention relates to racemic or optically active 1,3,4-benzotriazepin-5(4H)-one derivatives. The patent outlines a process for the preparation of these compounds, which can be used in pharmaceutical compositions for the treatment of various diseases. The new compounds correspond to a specific general formula, wherein R¹ represents hydrogen or straight or branched chain C₁-₄ alkyl, optionally carrying a pyridyl or a phenyl substituent.
Career Highlights
Antal Simai is associated with Egis Gyogyszergyar Rt., a prominent pharmaceutical company in Hungary. His work at Egis has allowed him to focus on the development of innovative pharmaceutical solutions that address critical health issues.
Collaborations
Throughout his career, Antal has collaborated with several talented individuals, including Ilona Bodi and Eva Gal. These collaborations have contributed to the advancement of his research and the successful development of new pharmaceutical compounds.
Conclusion
Antal Simai's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key inventor in the field. His work continues to influence the development of new therapeutic agents.